Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of 8.97 billion. The enterprise value is 10.44 billion.
| Market Cap | 8.97B |
| Enterprise Value | 10.44B |
Important Dates
The next estimated earnings date is Tuesday, March 3, 2026.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 38.38% |
| Owned by Institutions (%) | 62.88% |
| Float | 881.08M |
Valuation Ratios
The trailing PE ratio is 35.68 and the forward PE ratio is 28.93.
| PE Ratio | 35.68 |
| Forward PE | 28.93 |
| PS Ratio | 1.13 |
| PB Ratio | 6.82 |
| P/TBV Ratio | 9.71 |
| P/FCF Ratio | 28.00 |
| P/OCF Ratio | 15.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.93, with an EV/FCF ratio of 32.57.
| EV / Earnings | 41.51 |
| EV / Sales | 1.29 |
| EV / EBITDA | 12.93 |
| EV / EBIT | 22.12 |
| EV / FCF | 32.57 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 1.16.
| Current Ratio | 1.39 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 4.77 |
| Interest Coverage | 2.55 |
Financial Efficiency
Return on equity (ROE) is 20.38% and return on invested capital (ROIC) is 16.06%.
| Return on Equity (ROE) | 20.38% |
| Return on Assets (ROA) | 6.70% |
| Return on Invested Capital (ROIC) | 16.06% |
| Return on Capital Employed (ROCE) | 17.57% |
| Weighted Average Cost of Capital (WACC) | 5.93% |
| Revenue Per Employee | 113,439 |
| Profits Per Employee | 3,600 |
| Employee Count | 69,860 |
| Asset Turnover | 1.85 |
| Inventory Turnover | 3.59 |
Taxes
In the past 12 months, Raia Drogasil has paid 12.37 million in taxes.
| Income Tax | 12.37M |
| Effective Tax Rate | 4.63% |
Stock Price Statistics
The stock price has increased by +40.78% in the last 52 weeks. The beta is 0.14, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | +40.78% |
| 50-Day Moving Average | 4.56 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 66.29 |
| Average Volume (20 Days) | 27,591 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of 7.92 billion and earned 251.47 million in profits. Earnings per share was 0.15.
| Revenue | 7.92B |
| Gross Profit | 2.32B |
| Operating Income | 460.19M |
| Pretax Income | 267.15M |
| Net Income | 251.47M |
| EBITDA | 603.06M |
| EBIT | 460.19M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 101.02 million in cash and 1.53 billion in debt, with a net cash position of -1.43 billion.
| Cash & Cash Equivalents | 101.02M |
| Total Debt | 1.53B |
| Net Cash | -1.43B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 0.75 |
| Working Capital | 728.45M |
Cash Flow
In the last 12 months, operating cash flow was 583.78 million and capital expenditures -263.33 million, giving a free cash flow of 320.46 million.
| Operating Cash Flow | 583.78M |
| Capital Expenditures | -263.33M |
| Free Cash Flow | 320.46M |
| FCF Per Share | n/a |
Margins
Gross margin is 29.33%, with operating and profit margins of 5.81% and 3.17%.
| Gross Margin | 29.33% |
| Operating Margin | 5.81% |
| Pretax Margin | 3.37% |
| Profit Margin | 3.17% |
| EBITDA Margin | 7.61% |
| EBIT Margin | 5.81% |
| FCF Margin | 4.04% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 1.12%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 1.12% |
| Dividend Growth (YoY) | 30.83% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 37.97% |
| Buyback Yield | 1.02% |
| Shareholder Yield | 2.13% |
| Earnings Yield | 2.80% |
| FCF Yield | 3.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 24, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 24, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Raia Drogasil has an Altman Z-Score of 3.66 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 6 |